45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
2,842
Insurances with rates
19
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 28347663_1 | INJECTION, TREMELIMUMAB-ACTL, 1 MG | $105,300 | $63,180 | — | — | 17 |
| 27093436_1 | INJECTION, IPILIMUMAB, 1 MG | $30,061 | $18,036 | — | — | 19 |
| 28588186_1 | INJECTION, RISANKIZUMAB-RZAA, INTRAVENOUS, 1 MG | $26,476 | $15,886 | — | — | 17 |
| 27479903_1 | INJECTION, PEMBROLIZUMAB, 1 MG | $26,325 | $15,795 | — | — | 17 |
| 26736936_1 | INJECTION, NIVOLUMAB, 1 MG | $24,758 | $14,855 | — | — | 17 |
| 28499460_1 | INJECTION, RAMUCIRUMAB, 5 MG | $18,352 | $11,011 | — | — | 17 |
| 28571803_1 | INJECTION, OCTREOTIDE, DEPOT FORM FOR INTRAMUSCULAR INJECTION, 1 MG | $18,298 | $10,979 | — | — | 19 |
| 28515651_1 | INJECTION, RITUXIMAB-PVVR, BIOSIMILAR, (RUXIENCE), 10 MG | $15,199 | $9,119 | — | — | 17 |
| 3342004_1 | LEUPROLIDE ACETATE (FOR DEPOT SUSPENSION), 7.5 MG | $13,944 | $8,366 | — | — | 19 |
| 28563180_1 | INJECTION, ANIFROLUMAB-FNIA, 1 MG | $13,505 | $8,103 | — | — | 17 |
| 28524660_1 | INJECTION, MEPOLIZUMAB, 1 MG | $9,670 | $5,802 | — | — | 17 |
| 28451063_1 | INJECTION, INCLISIRAN, 1 MG | $8,996 | $5,397 | — | — | 17 |
| 27824696_1 | INJECTION, NIVOLUMAB, 1 MG | $7,514 | $4,508 | — | — | 17 |
| 27078472_1 | INJECTION, INFLIXIMAB-DYYB, BIOSIMILAR, (INFLECTRA), 10 MG | $7,330 | $4,398 | — | — | 17 |
| 25265318_1 | 00173-0881-01 - mepolizumab 100 mg Pow | $6,750 | $4,050 | — | — | 17 |
| 28092950_1 | INJECTION, BEVACIZUMAB-BVZR, BIOSIMILAR, (ZIRABEV), 10 MG | $6,625 | $3,975 | — | — | 17 |
| 28420514_1 | INJECTION, NIVOLUMAB, 1 MG | $6,105 | $3,663 | — | — | 17 |
| 1299617_4 | Destruction of lining of uterus using ultrasound guidance | $5,905 | $3,543 | — | — | 13 |
| 27208179_1 | INJECTION, ABATACEPT, 10 MG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT S | $5,573 | $3,344 | — | — | 19 |
| 735104_4 | INJECTION, LEUPROLIDE ACETATE (FOR DEPOT SUSPENSION), PER 3.75 MG | $5,382 | $3,229 | — | — | 19 |
| 723165_4 | Exam of uterus with destruction of lining of uterus using an endoscope | $5,014 | $3,008 | — | — | 15 |
| 723213_4 | Vaginal delivery with care before and after delivery | $4,991 | $2,995 | — | — | 15 |
| 2933825_4 | INJECTION, DENOSUMAB, 1 MG | $4,689 | $2,813 | — | — | 19 |
| 723172_4 | Biopsy of lining of uterus and/or removal of polyp using an endoscope | $4,296 | $2,578 | — | — | 15 |
| 25536149_4 | INJECTION, DENOSUMAB, 1 MG | $4,290 | $2,574 | — | — | 19 |
| 27506610_1 | INJECTION, RAMUCIRUMAB, 5 MG | $4,253 | $2,552 | — | — | 17 |
| 1168161_1 | 615 - MRI-Head and neck | $3,962 | $2,377 | — | — | 17 |
| 3507145_1 | LABOR ROOM/DELIVERY - DELIVERY ROOM | $3,763 | $2,258 | — | — | 17 |
| 7793141_4 | INJECTION, ONABOTULINUMTOXINA, 1 UNIT | $3,630 | $2,178 | — | — | 19 |
| 723258_4 | Removal of ovaries and/or tubes using an endoscope | $3,591 | $2,155 | — | — | 15 |
| 739063_4 | Removal of growth of uterus through abdomen, 1-4 growths | $3,589 | $2,153 | — | — | 13 |
| 25761809_4 | HYALURONAN OR DERIVATIVE, MONOVISC, FOR INTRA-ARTICULAR INJECTION, PER DOSE | $3,567 | $2,140 | — | — | 17 |
| 723231_4 | Cesarean delivery with care after delivery | $3,539 | $2,123 | — | — | 15 |
| 26339058_4 | HYALURONAN OR DERIVATIVE, SYNVISC OR SYNVISC-ONE, FOR INTRA-ARTICULAR INJECTION, 1 MG | $3,415 | $2,049 | — | — | 19 |
| 723228_4 | Cesarean delivery | $3,287 | $1,972 | — | — | 15 |
| 1299606_4 | Removal of uterus through abdomen using an endoscope, 250.0 g or less | $3,281 | $1,969 | — | — | 13 |
| 3307798_4 | Insertion of central venous tube with port (5 years or older) | $3,230 | $1,938 | — | — | 15 |
| 739064_4 | Removal of uterus and cervix through abdomen | $3,228 | $1,937 | — | — | 15 |
| 3507142_1 | LABOR ROOM/DELIVERY - DELIVERY ROOM | $3,227 | $1,936 | — | — | 17 |
| 723183_4 | Removal of growth of uterus using an endoscope, 250.0 g or less | $3,075 | $1,845 | — | — | 13 |
| 667636_4 | Biopsy of cervix using an endoscope with loop electrode | $3,012 | $1,807 | — | — | 13 |
| 1168160_1 | 611 - MRI - BRAIN | $3,000 | $1,800 | — | — | 17 |
| 741062_4 | Release of small bowel scar tissue using an endoscope | $2,955 | $1,773 | — | — | 13 |
| 725083_4 | Plastic repair of vagina and tissue separating vagina, rectum, and bladder | $2,846 | $1,708 | — | — | 15 |
| 3671300_4 | Drainage of pelvic abscess, transvaginal or transrectal approach, percutaneous | $2,840 | $1,704 | — | — | 4 |
| 26158319_1 | INJECTION, FERRIC CARBOXYMALTOSE, 1 MG | $2,793 | $1,676 | — | — | 17 |
| 1297329_1 | 341 - NUC MED/DX | $2,754 | $1,653 | — | — | 17 |
| 25761808_4 | HYALURONAN OR DERIVATIVE, GEL-ONE, FOR INTRA-ARTICULAR INJECTION, PER DOSE | $2,750 | $1,650 | — | — | 19 |
| 882001_1 | 610 - MRI | $2,727 | $1,636 | — | — | 17 |
| 723240_4 | Removal of ovarian or tubal pregnancy with removal of ovaries | $2,685 | $1,611 | — | — | 13 |
Showing top 50 of 2,842 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.